T

Triveni Bio

Develops functional antibodies for precision medicine

Senior Scientist - Translational Research

Translational Research & Bench BiologyPosted on Nov 13
Full-timeWatertown, MA, USA

About the Job

Requirements

  • A Ph.D. in molecular biology or a related discipline and at least 5 years of relevant experience in academia, the pharmaceutical industry, biotechnology, or a combination thereof.
  • A strong background in immunology and inflammation.
  • Hands-on expertise in preclinical in vivo pharmacology and animal disease models.
  • Demonstrated expertise in functional assays, including ELISA, quantitative reverse transcription PCR (qRT-PCR), Western blotting, immunohistochemistry, and immunofluorescence.
  • A proven track record of managing contract research organizations (CROs), external vendors, and academic partnerships.
  • The ability to independently manage projects and work effectively with cross-functional teams.

Responsibilities

  • Play a key role in developing new biologic drugs for immunotherapy by independently proposing, planning, and performing in vivo and in vitro studies to characterize drug candidates and their mechanisms of action.
  • Design, develop, troubleshoot, and establish in vivo models and in vitro assays to evaluate the biological efficacy of novel therapeutic agents.
  • Manage external research activities with CROs and academic collaborators, ensuring timelines, deliverables, and data quality.
  • Present research findings at internal meetings, contribute to external scientific discussions, and prepare scientific reports and summaries.
  • Provide technical guidance, mentorship, and troubleshooting support to junior associates.

Desired Qualifications

  • Experience in dermatology.

About the Company

Triveni Bio

Develops functional antibodies for precision medicine

Triveni Bio develops therapeutics by creating functional antibodies for immunological and inflammatory disorders using genetics-informed precision medicine in a B2B licensing model. Using a proprietary platform, it identifies targets with strong genetic rationale, designs and validates antibodies against them, and predicts patient subpopulations to understand disease mechanisms. It differentiates itself by combining genetics-backed target discovery, functional antibody development, and patient stratification in a single platform, reducing risks for novel targets. Its goal is to supply the biopharmaceutical industry with precise antibody therapies and related technologies to enable targeted treatments for defined patient groups.

Company size
51-200
Company stage
Series C
Total funding
$288.4M
Headquarters
Watertown, MA
Founded
Not listed

Recently Posted Jobs

Explore more opportunities at Triveni Bio

See more jobs